Before becoming Director, Dr. Broder had been, since 1981, Associate Director for the Clinical Oncology Program in NCI's Division of Cancer Treatment. He came to NCI as a clinical associate in the Metabolism Branch of the Division of Cancer Biology and Diagnosis in 1972. In 1975, he became an investigator in the Medicine Branch, DCT, and returned to the Metabolism Branch as a senior investigator.
Dr. Broder's research has centered on the biology of the immune system with emphasis on abnormal immunoregulation in cancer, and on the relationship between cancer and immunodeficiency states including AIDS. Dr. Broder and his co-workers identified certain types of suppressor cells which induced immune impairment in some cancer patients. He and his co-workers also identified and characterized neoplasms which arose from helper and suppressor cells. In addition to his cancer research, Dr. Broder and his co-workers have worked on drug development, taking drugs rapidly from the test tube to patients, for the treatment of AIDS and related disorders. He is the recipient of numerous scientific awards and is a member of the Institute of Medicine. His major focus as Director has been the need to ensure balance among the three foundation stones of the Institute: basic research, clinical trials (in prevention and therapy), and cancer centers. He has also focused on the relationship between poverty and cancer.
Dr. Broder obtained his undergraduate and medical degrees from the University of Michigan. His internship and residency were at Stanford University. He is board certified in Internal Medicine and in Medical Oncology.
Return to 1993 Factbook Table of contents
Return to NCI Homepage